ADVERTISEMENT

This site is intended for non healthcare professionals. For the professional site, please click here

08/13/2009 - News

FDA Approves New Cholesterol Drug

By: June Chen, MD

Tools:
  • Print this page
  • Bookmark this page
  • Forward this page to a friend
  • Digg
  • Reddit
  • Facebook
  • Twitter

Last week, the U.S. Food and Drug Administration (FDA) approved pitavastatin, a new cholesterol-lowering drug. Pitavastatin is indicated for the primary treatment of high cholesterol and combined dyslipidemia.

Pitavastatin, which will be marketed as Livalo®, is the newest statin therapy to be introduced for cholesterol-lowering. The FDA’s approval of pitavastatin is based upon evidence from five Phase III trials demonstrating its efficacy in lowering low density lipoprotein (LDL) cholesterol in elderly patients, diabetics, and patients at higher cardiovascular risk.
 
Livalo is expected to launch in the U.S. in early 2010, and this cholesterol-lowering drug will be available in three dosages.
 

Source:

U.S. Food and Drug Administration website, accessed August 5, 2009.

Created on: 08/13/2009
Reviewed on: 08/13/2009

Your rating: None
Read more about:
Tools:
  • Print this page
  • Bookmark this page
  • Forward this page to a friend
  • Digg
  • Reddit
  • Facebook
  • Twitter

Add your comment

  • Allowed HTML tags: <p><b><em> <strong> <cite> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.
Click here to subscribe to the comments

ADVERTISEMENT



Alzheimer test

Information For Caregivers

IAGG Webcast